Skip to content
for a responsible, fair & sustainable food system

Briefings

Detailed, referenced briefings and other detailed documents on a range of GM-related topics. Most have been created by GM Freeze but we also include some from our members or partners where they are the experts on this topic.


In Two Minds – EFSA GMO Panel concedes Bt crop risks but approves with mitigation

13 Dec 2011

Papering Over the Cracks: EFSA’s opinion on cultivating GM MON88017 maize in Europe – Mitigation is not enough

7 Dec 2011

The Bill and Melinda Gates Foundation, Biotechnology and Intensive Farming

31 Oct 2011

Full Briefing

Download file

Objecting to an Application to Trial GM Wheat in Hertfordshire

7 Jul 2011

Further information and details on how to object to Defra to the Rothamsted Research application to trial GM wheat in the UK in 2012-2013.

Herbicide Tolerance and GM Crops – Why the world should be ready to round up glyphosate

30 Jun 2011

A comprehensive report by GM Freeze and Greenpeace on the environmental and health risks posed by glyphosate in agriculture.

Plant Breeding and Crop Yields – Can we rely on GM to increase yield?

31 May 2011

Maternal and Foetal Exposure to Pesticides Associated to Genetically Modified Foods in Eastern Townships of Quebec, Canada

20 May 2011

Maternal and Foetal Exposure to Pesticides Associated to Genetically Modified Foods in Eastern Townships of Quebec, Canada

Study Summary and Demand for Urgent Regulatory Action

Whole toxic GM Bt proteins found in human and foetal blood.

Letter to Caroline Spelman re: EFSA guidance for the environmental risk assessment of genetically modified plants

5 May 2011

Letter to Caroline Spelman

Download file

Letter to Caroline Spelman - Annex

Download file

Blind Faith: An analysis of the DG Sanco report on the socio-economic implications of GMO cultivation

3 May 2011

Update on Cloning of Animals for Food Production

1 Jan 2011

This briefing provides details and background on the presence of the offspring of cloned cattle in the UK and the implications of these highly controversial developments for health, animal welfare and consumer choice.